Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€1.28

€1.28

-4.280%
-0.058
-4.280%
€43.32

€43.32

 
22:26 / Tradegate WKN: A3CSM8 / Symbol: TPST / Name: Tempest Therapeutics / Stock / Small Cap /
Latest predictions
€42.80
15.08.24
-15.34%
buy
04.08.24
-9.19%
04.08.24
-9.19%
€7.48
21.06.24
-31.53%
buy
€43.87
20.06.24
-34.31%
buy
€43.62
10.05.24
-57.56%
buy
Your prediction

Tempest Therapeutics Inc. Stock

Heavy losses for Tempest Therapeutics Inc. today as the stock fell by -€0.058 (-4.280%).
With 8 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
Based on the current price of 1.28 € the target price of 43 € shows a potential of 3272.55% for Tempest Therapeutics Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Tempest Therapeutics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Valuation (undervalued/overvalued)" there were negative voices in the community.

Pros and Cons of Tempest Therapeutics Inc. in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

The financials of Tempest Therapeutics (TPST), while intriguing, present a rather mixed picture. With the biotech industry often characterized by volatility and uncertainty, it’s essential to delve deep into the numbers to grasp the overall financial health of the company. Tempest Therapeutics is currently navigating a challenging landscape, and an examination of its financial ratios, valuation metrics, and overall performance reveals both potential opportunities and significant risks.

*Pros: *

Enterprise Value Insight: The Enterprise Value (EV) of approximately $56 million indicates the total value of the company, accounting for its market capitalization along with debt and excluding cash and cash equivalents. This number can provide insightful context when evaluating how the market values Tempest Therapeutics relative to its operational performance.

Comments

Prediction Buy
Perf. (%) -15.34%
Target price 42.798
Change
Ends at 15.08.25

Tempest Therapeutics, Inc. (NASDAQ: TPST) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $47.00 price target on the stock.
Ratings data for TPST provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -31.53%
Target price 7.478
Change
Ends at 21.06.25

Tempest Therapeutics, Inc. (NASDAQ: TPST) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $8.00 price target on the stock.
Ratings data for TPST provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -34.31%
Target price 43.875
Change
Ends at 20.06.25

Tempest Therapeutics, Inc. (NASDAQ: TPST) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $47.00 price target on the stock.
Ratings data for TPST provided by MarketBeat
Show more